Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study (Q33956796)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study
scientific article

    Statements

    Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study (English)
    Michael W Fried
    Peter Ferenci
    Ira Jacobson
    Michael Manns
    Morris Sherman
    Leen Gilles
    Oliver Lenz
    Monika Peeters
    Vanitha Sekar
    Goedele De Smedt
    Maria Beumont-Mauviel
    11 October 2013
    1918-1929

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit